Posted by Michael Wonder on 20 Aug 2019
NICE’s track record in cancer drugs: the impact of the CDF and interim funding
20 August 2019 - Cancer drugs and the decisions made by the UK’s NICE have been subject to much scrutiny and more than a little controversy.
There’s been much debate too. All of this has led to some policy fudges through the introduction of a Cancer Drugs Fund.
The Fund first came into being in 2010 before going through a reform in 2016. By 2019, we can look back and see what the impact of the Fund has been on NICE recommendations using NICE’s new downloadable excel sheet on cancer Technology Appraisals.
